Neurocrine Biosciences (NBIX) Misses Q3 EPS by 15c
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.35 -1.49%
Revenue Growth %: +30.8%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +30.8%
Financial Fact:
General and administrative: 17.49M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of ($0.40), $0.15 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo upgrades S&P 500 Industrials to favorable
- UBS Reiterates Neutral Rating on Helen of Troy (HELE)
- Iovance shares jump in premarket as raised outlook clears consensus views
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
